Antibody technology

Antibodies are important tools for medical applications as well as for experimental research. The majority of antibodies are composed of two heavy chains and two light chains, where both chains contribute to the antigen-binding site. Camelids and sharks produce antibodies consisting only of heavy chains. This format shows a number of favorable properties. A further improvement of these molecules is achieved by a new antibody format – dimers of variable domains of the heavy chains.

Further Information: PDF

ESA Patentverwertungsagentur Sachsen-Anhalt GmbH
Phone: +49 (0)391/8 10 72 20

Contact
Dr. Stefan Schünemann

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Silicon Carbide Innovation Alliance to drive industrial-scale semiconductor work

Known for its ability to withstand extreme environments and high voltages, silicon carbide (SiC) is a semiconducting material made up of silicon and carbon atoms arranged into crystals that is…

New SPECT/CT technique shows impressive biomarker identification

…offers increased access for prostate cancer patients. A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more…

How 3D printers can give robots a soft touch

Soft skin coverings and touch sensors have emerged as a promising feature for robots that are both safer and more intuitive for human interaction, but they are expensive and difficult…

Partners & Sponsors